Safety of celecoxib compared with placebo and non-selective NSAIDs: cumulative meta-analysis of 89 randomized controlled trials (Q45022824)

8 December 2017

0 references

Safety of celecoxib compared with placebo and non-selective NSAIDs: cumulative meta-analysis of 89 randomized controlled trials (English)

1 reference

8 December 2017

1 reference

ChEBI release 2020-05-28

1 reference

Margaret Noyes Essex

1

1 reference

8 December 2017

Richard Y Zhang

2

1 reference

8 December 2017

Manuela F Berger

3

1 reference

8 December 2017

Sameer Upadhyay

4

1 reference

8 December 2017

Peter W Park

5

1 reference

8 December 2017

language of work or name

English

0 references

publication date

19 March 2013

1 reference

Expert Opinion on Drug Safety

8 December 2017

1 reference

8 December 2017

12

1 reference

8 December 2017

4

1 reference

8 December 2017

465-477

1 reference

American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee

8 December 2017

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.780595

Gastrointestinal tolerability of NSAIDs in elderly patients: a pooled analysis of 21 randomized clinical trials with celecoxib and nonselective NSAIDs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.780595

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.780595

Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.780595

Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.780595

Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.780595

Subgroup analyses to determine cardiovascular risk associated with nonsteroidal antiinflammatory drugs and coxibs in specific patient groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.780595

Managing the adverse effects of nonsteroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.780595

Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.780595

Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.780595

Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.780595

Comparative efficacy and safety of celecoxib and naproxen in the treatment of osteoarthritis of the hip.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.780595

Celecoxib versus diclofenac in the management of osteoarthritis of the knee

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.780595

Patient Preference for Placebo, Acetaminophen (paracetamol) or Celecoxib Efficacy Studies (PACES): two randomised, double blind, placebo controlled, crossover clinical trials in patients with knee or hip osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.780595

Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.780595

Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.780595

Efficacy of celecoxib, a cyclooxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis: a six-week controlled study with comparison against placebo and against a conventional nonsteroidal antiinflammatory drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.780595

Comparison of two different dosages of celecoxib with diclofenac for the treatment of active ankylosing spondylitis: results of a 12-week randomised, double-blind, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.780595

Celecoxib: a review of its use in the management of arthritis and acute pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.780595

Celecoxib in the treatment of primary dysmenorrhea: results from two randomized, double-blind, active- and placebo-controlled, crossover studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.780595

Reporting cumulative proportion of subjects with an adverse event based on data from multiple studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.780595

Recommendations for safety planning, data collection, evaluation and reporting during drug, biologic and vaccine development: a report of the safety planning, evaluation, and reporting team

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.780595

Strategies for comparing treatments on a binary response with multi-centre data

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.780595

Risk of cardiovascular events in patients receiving celecoxib: a meta-analysis of randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.780595

Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.780595

Time dependent risk of gastrointestinal complications induced by non-steroidal anti-inflammatory drug use: a consensus statement using a meta-analytic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.780595

A randomized, multicentre, double-blind, parallel-group study to assess the adverse event-related discontinuation rate with celecoxib and diclofenac in elderly patients with osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.780595

Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.780595

Incidence of gastroduodenal ulcers during treatment with celecoxib or diclofenac: pooled results from three 12-week trials in Chinese patients with osteoarthritis or rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.780595

Analgesic effectiveness of celecoxib and diclofenac in patients with osteoarthritis of the hip requiring joint replacement surgery: a 12-week, multicenter, randomized, double-blind, parallel-group, double-dummy, noninferiority study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.780595

Determine whether perioperative celecoxib administration would reduce opioid consumption and provide effective pain relief in patients undergoing arthroscopic knee surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.780595

Analgesic efficacy of celecoxib in postoperative oral surgery pain: a single-dose, two-center, randomized, double-blind, active- and placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.780595

Efficacy and safety of celecoxib in the treatment of acute pain due to ankle sprain in a Latin American and Middle Eastern population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.780595

Efficacy and Tolerability of Celecoxib in the Treatment of Acute Gouty Arthritis: A Randomized Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.780595

10.1517/14740338.2013.780595

21 January 2018

Identifiers

DOI

1 reference

8 December 2017

1 reference